Story perspectives

Australia Urged to Regulate GLP-1 Weight-Loss Telehealth Sales

12/31/2025

Summary

Story summary

Peak eating disorder organizations in Australia warn that telehealth marketing of GLP-1 weight-loss treatments lacks adequate medical monitoring.
The company Juniper has faced scrutiny for promotional tactics, including a controversial Black Friday sale.
Advocates argue that in-person consultations should be mandated for safety.
The Royal Australian College of General Practitioners clarified it does not endorse Juniper, amid rising calls for stronger regulations.

1 of 1

Story summary

Peak eating disorder organizations in Australia warn that telehealth marketing of GLP-1 weight-loss treatments lacks adequate medical monitoring.
The company Juniper has faced scrutiny for promotional tactics, including a controversial Black Friday sale.
Advocates argue that in-person consultations should be mandated for safety.
The Royal Australian College of General Practitioners clarified it does not endorse Juniper, amid rising calls for stronger regulations.